Skip to main content
PLOS One logoLink to PLOS One
. 2025 Sep 8;20(9):e0331755. doi: 10.1371/journal.pone.0331755

Outcomes and complications among nonagenarians undergoing cardiac surgery: A scoping review

Laurence Weinberg 1,2,*, Jarryd Ludski 1, Bradly Carp 1, Je Min Suh 1, Anoop N Koshy 3,4, Cilla Haywood 2,5, Benjamin Churilov 1, Dong-Kyu Lee 6, Michael Yii 7
Editor: Redoy Ranjan8
PMCID: PMC12416686  PMID: 40920802

Abstract

Introduction

This review was aimed at understanding the scope of evidence regarding outcomes and complications in nonagenarians (90–99 years of age) undergoing open cardiac surgery.

Methods

The review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Extension for Scoping Review Protocol guidelines. A search of three databases, MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials, identified articles pertaining to nonagenarians undergoing various open cardiac surgical procedures. No restrictions were applied to study design or publication date.

Results

From the initial 1826 articles identified, we included 28 studies from eight countries in a total of 6411 nonagenarians. The median 30-day mortality rate was 10.5% (IQR 7.2–14.6). Postoperative complication rates were reported in 20 studies (71%), and the median major complication rate was 71.4%. Respiratory, cardiac, renal, neurologic, gastrointestinal, and/or infectious complications were reported in 19%, 20%, 14%, 18%, 5%, and 9% of cases, respectively. The median length of hospital stay was 12.5 days (IQR 10.4–18.0). No studies reported unplanned readmissions to the intensive care unit or detailed patient-centered outcome measures.

Conclusions

Although age alone should not preclude nonagenarians from undergoing cardiac surgery, the procedure is associated with a significantly elevated risk of morbidity and a relatively high mortality rate. The review findings emphasize the need for international registry data to identify risk factors associated with adverse outcomes, explore strategies to decrease the risk of major complications, and improve postoperative quality of life. Moreover, creating and implementing uniform preoperative frailty assessments, and correlating them with surgical outcomes, will be crucial. Developing standardized patient-reported experience and outcome measures will also be imperative. Scoping review registered on OSF registries (https://osf.io/4mg7n).

Introduction

Global life expectancy has markedly increased. In many countries, the life expectancy exceeds 85 years, particularly among women [1]. Consequently, the expanding population of nonagenarians, individuals 90–99 years of age, is the fastest-growing demographic within the older population [2]. This demographic transformation underscores the growing importance of addressing the unique healthcare needs and challenges faced by this rapidly expanding age group. Historically, cardiac surgical options for nonagenarians have been limited; however, advancements in surgical techniques and anesthesia have increasingly enabled nonagenarians to safely undergo such procedures [3].

Given that ischemic and valvular heart disease, and acute coronary syndromes are highly prevalent among older people [48], the number of nonagenarians expected to undergo cardiac surgery is anticipated to rise. Because ischemic and valvular heart disease remains prevalent in people ≥90 years of age [48], and the nonagenarian population is projected to exceed 30 million people by 2030 [2], a clear and yet underexplored gap exists in age-specific perioperative outcome data. Nonagenarians often present with multiple comorbidities that decrease their functional reserves, thereby heightening their susceptibility to postoperative complications and increasing their mortality risk [9,10]. Despite the well-documented rise in the incidence of cardiovascular disease among nonagenarians and the increasing number of patients undergoing cardiac surgeries [3,11], data specific to this demographic and adequate information on age-specific outcomes remain lacking. Understanding these parameters will be crucial for guiding future research and equipping healthcare providers with the resources necessary to meet the surgical needs of nonagenarians. These findings might also substantially affect the allocation of healthcare resources. Therefore, we conducted a scoping review to identify critical knowledge gaps in the literature, to provide a foundation for guiding research aimed at advancing the understanding of nonagenarians undergoing cardiac surgery.

Objectives

This review provides an overview of the current landscape of cardiac surgery in nonagenarians, detailing inpatient, 30-day, and long-term complication and mortality rates. Additionally, the review evaluates key metrics, such as the lengths of intensive care unit (ICU) and hospital stays, as well as the frequency of inpatient and hospital readmissions. Finally, as an exploratory outcome, the review identified whether patient-reported outcomes (PROMs) and experience measures (PREMs) have been included in studies examining outcomes in nonagenarians undergoing cardiac surgery, given that an absence of such data would itself constitute a notable finding. By addressing these objectives, this review highlights critical aspects of perioperative care and identifies gaps in the existing literature, to better inform future clinical practice and research.

Materials and methods

Study methods

This review was conducted to examine the scope of the existing literature on the outcomes and complications associated with cardiac surgery in nonagenarians. Anticipating a dearth of comprehensive studies, we used a broad search encompassing both peer-reviewed and grey literature mentioning “nonagenarians,” “cardiac surgery,” and related terms. Grey literature refers to materials produced outside commercial publishing and traditional academic frameworks, including institutional reports (e.g., government-issued policy documents), conference materials (e.g., proceedings and abstracts), and organizational publications (e.g., professional association guidelines or collaborative research group working papers).

This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Extension for Scoping Reviews (PRISMA-ScR) guidelines (S1 Table), to ensure methodological rigor and transparency throughout the review process [12]. We systematically reviewed the existing literature and applied the methodological frameworks of Arksey and O’Malley [13] and Levac et al. [14]. These methods have been described in detail in the scoping review protocol [15].

Protocol and registration

The study protocol was developed in collaboration with senior perioperative physicians specializing in cardiac surgery, to ensure a robust and clinically relevant approach. The protocol was designed to prioritize comprehensive evaluation of clinical outcomes following cardiac surgery in nonagenarians, addressing the unique challenges and considerations associated with this rapidly growing demographic. The protocol underwent peer review and was published in BMJ Open [15]. This process ensured effective protocol dissemination, public accessibility, and transparency. The review was also registered on Open Science Framework registries (https://osf.io/4mg7n).

Ethical considerations

This study relied on secondary data analysis, which is available in database of scientific literature and, therefore, it did not require submission to the Austin Health Human Research Ethics Committee. All analysis of data were conducted in accordance with the ethical standards of the research committee and with the 1964 Declaration of Helsinki and its later amendments.

Search strategy

A search of three databases, MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials, identified articles pertaining to nonagenarians undergoing various open cardiac surgical procedures. To ensure comprehensive literature coverage, we identified supplementary studies through manual tracking of the references in the included articles. The search strategy is presented in S2 Table.

Types of studies

Studies and abstracts deemed eligible for inclusion in this review are summarized in Table 1. Editorials, study protocols, and dissertations were excluded from consideration, to maintain the focus on original research and ensure methodological rigor.

Table 1. Inclusion and exclusion criteria.

Inclusion Exclusion
Population • Participants 90–99 years of age (nonagenarians) • Participants younger than 90 years or older than 100 years
Concept • Studies evaluating complications, mortality, or any clinical outcomes among nonagenarians undergoing cardiac surgery
• Studies evaluating psychosocial or behavioral outcomes
• Studies focused on non-health outcomes, e.g., health economic evaluations
Context • Assessment of perioperative outcomes in nonagenarians undergoing open cardiac surgical interventions
Types of evidence • Primary empirical research studies (e.g., randomized controlled trials, cohort studies, cross-sectional studies, or case reports)
• Full-text articles, including abstracts, written in English
• Published abstracts or posters
• Grey literature, including published government reports and policy documents, conference proceedings and abstracts, professional association publications, and published working papers from research groups or committees
• Editorial articles (e.g., perspective pieces or position statements)
• Study protocols
• Dissertations
• Clinical trial registries
• Preprints and non-peer-reviewed research reports

Eligibility criteria

This review incorporated publications (with no start date restriction, published until August 29, 2023) reporting data on patients 90–99 years of age. The included literature comprised primary empirical studies, randomized controlled trials, cross-sectional studies, cohort studies, and case reports, alongside full-text conference proceedings, abstracts, and posters. Non-English manuscripts were excluded unless they were accompanied by an English-language abstract meeting the eligibility criteria, in which case the full text was translated for evaluation. Restricting the search to English-language sources, despite potentially introducing geographic bias and limiting the generalizability of the findings, ensured methodological consistency in analysis and interpretation. This approach aligned with the exploratory nature of this review, which was aimed at systematically mapping available evidence rather than synthesizing global findings. Notably, a recent review supports that such language restrictions have minimal influence on the effect estimates or conclusions in most cases [16].

Given that the key aim of this review was to provide a synopsis of cardiac surgery in nonagenarians, the eligibility criteria included a wide range of open cardiac surgical procedures, as reported in the scoping review protocol [15]. These procedures encompassed coronary artery bypass grafting (CABG) and any valvular surgery (e.g., aortic, mitral, tricuspid, or pulmonary valve repair or replacement), atrial or ventricular septal defect closures; minimally invasive valvular surgeries requiring cardiopulmonary bypass, surgeries on the ascending aorta or aortic arch via sternotomy or thoracotomy, including hybrid stent-graft prostheses such as the frozen elephant Trunk procedure; heart transplantation; ventricular assist device implantation; left ventricular aneurysmectomy; surgeries on the descending aorta via sternotomy or thoracotomy (e.g., thoracoabdominal aortic repair or replacement); and removal of cardiac tumors or masses, with or without cardiopulmonary bypass.

Because they did not involve open-heart surgery, transcatheter aortic valve replacement and transcatheter aortic valve implantation procedures were excluded from this review. We also excluded any percutaneous or transapical valvular implants or interventions, e.g., mitral valve clip implantation. Finally, open and endovascular abdominal aortic repairs, as well as thoracic endovascular aortic repairs, were excluded. These exclusions ensured a focus solely on the outcomes of open-heart surgical interventions. Further details regarding these procedures can be found in the publications selected for review [1744] and their respective reference lists.

Study selection and screening procedure

A two-step screening process was conducted with the Covidence® web-based review platform. Our search identified eligible studies, and duplicates were excluded. A pilot test using our predefined eligibility criteria was then conducted on 200 randomly selected articles, to ensure the robustness of the data collection instruments before the full study. This test, performed by two authors (JL and BC), was also used to calibrate the reviewers’ use of screening protocols and ensure uniform application of the selection criteria.

The pilot review process led to the inclusion of nine studies and the exclusion of 191 studies, thus demonstrating the rigor of the selection method. Reviewer agreement was high, with a 95.6% concordance rate and a Cohen’s kappa coefficient of 0.643, indicating substantial inter-rater reliability. Full-text publications of all relevant and potentially eligible studies were retrieved and independently screened by two reviewers (JL and BC). Discrepancies were resolved through adjudication by a third reviewer (LW). Studies not meeting the inclusion criteria were excluded, and the entire process was systematically documented in adherence with PRISMA guidelines to ensure transparency and reproducibility.

Data extraction

The included studies were systematically charted in a customized data extraction form to ensure comprehensive, standardized collection of all relevant information, as previously reported [15]. Postoperative outcomes were meticulously captured, including complications, inpatient mortality, and mortality rates at 30 days, 1 year, 5 years, and 10 years. Additionally, PROMs and PREMs were extracted to assess long-term effects from the patient perspective. This systematic approach ensured a robust dataset for analysis and synthesis.

Data synthesis and analysis

Data analysis was conducted in GraphPad Prism (v10.4.1, GraphPad Software, San Diego, CA, USA). Continuous variables were assessed for normality with the Kolmogorov–Smirnov test and/or Q-Q plot visual inspection. Normally distributed data are presented as mean ± standard deviation, whereas nonparametric data are summarized as median (interquartile range [IQR]) with full range (minimum–maximum). Categorical variables were analyzed with the chi-square test or Fisher’s exact test, depending on the expected cell frequencies. For studies with substantial heterogeneity, a narrative-synthesis approach was used to contextualize patient-reported outcomes. A comparative analysis of study designs and participant characteristics was performed to identify research gaps.

This process, through systematically examining variations in methods and demographic profiles across studies, highlighted areas in which the existing evidence is limited or inconsistent, to potentially guide future research priorities and enhance understanding of the investigated topic. Our approach can therefore be accurately described as a narrative synthesis of quantitative findings, organized thematically around clinical domains (mortality, morbidity, and length of stay). This methodological flexibility enabled nuanced exploration of the complexity present in the literature while maintaining adherence to a coherent analytical framework. This framework facilitated the identification of knowledge gaps and the recognition of emerging trends within the field.

Patient and public involvement

This scoping review exclusively analyzed existing research and did not involve members of the public or direct participation from patients in its design, conduct, or dissemination.

Results

Study selection

From the initial screening process, a total of 1826 articles were identified. An additional 20 articles were identified through a search of the grey literature and reference tracking, to supplement the primary database search. However, no eligible articles were identified from the grey literature. In total, 81 full-text publications were assessed for eligibility, among which 28 studies [17–44] met the inclusion criteria and were included in the final analysis. The PRISMA flow diagram detailing the selection of studies is presented in Fig 1.

Fig 1. Study selection flow diagram.

Fig 1

Although a narrative synthesis approach was used for quantitative data, no qualitative themes were identified. In addition, our findings are descriptive and were derived from unweighted medians rather than means or pooled statistics, to avoid overinterpretation.

Study characteristics

All studies included in our review were reported in English (abstract and/or full text) and published between 1994 and 2022. The findings reported in these studies were collected between 1983 and 2019, during a median collection period of 9 years. All studies were retrospective in design. Whereas 18 studies (64%) were performed in the United States [1722,25,26,28,3437,3943], the others were performed in Canada [22], the United Kingdom [23,27], Germany [31,32], Saudi Arabia [29], Australia [44], France [24], Japan [38], and Italy [30]. A total of 19 studies (68%) were performed in public hospitals [1727,3134,3739,41], four (14%) were performed in private hospitals [30,35,40,42], and three (10%) were performed in both public and private facilities [28,36,44]. Study characteristics and outcome measures are presented in Table 2.

Table 2. Key characteristics of the included publications.

Authors Year of publication Data collection period Country Institution No. of patients Male Female
Tsai et al. [17] 1994 1983–1993 United States Public 15 10 5
Samuels et al. [18] 1996 1987–1995 United States Public 14 7 7
Blanche et al. [19] 1997 1986–1995 United States Public 30 18 12
Miller et al. [20] 1999 1987–1996 United States Public 11 7 4
Bacchetta et al. [21] 2003 1993–2002 United States Public 42 20 22
Bridges et al. [22] 2003 1997–2000 United States and Canada Public 1092 551 541
Edwards et al. [23] 2003 1986–2000 United Kingdom Public 35 17 18
Levy Praschker et al. [24] 2006 1990–2002 France Public 30 11 18
Roberts et al. [25] 2006 2000–2006 United States Public 9 6 3
Hovanesyan et al. [26] 2007 1996–2006 United States Public 22 7 14
Guilfoyle et al. [27] 2008 1998–2007 United Kingdom Public 23 13 10
Ullery et al. [28] 2008 1995–2004 United States Public/Private 49 25 24
Hajabed et al. [29] 2010 2007–2009 Saudi Arabia 12 10 2
Speziale et al. [30] 2010 1998–2008 Italy Private 127 62 65
Easo et al. [31] 2013 2000–2007 Germany Public 17 6 11
Assmann et al. [32] 2013 1995–2011 Germany Public 49 32 17
Caceres et al. [33] 2013 1983–2011 United States Public 154 91 63
Davis et al. [34] 2014 2002–2012 United States Public 108 61 47
Murashita et al. [35] 2014 1993–2013 United States Private 33 12 21
Mack et al. [36] 2015 2007–2013 United States Public/Private 20 8 12
George et al. [37] 2016 2001–2012 United States Public 119 67 52
Ohnuma et al. [38] 2016 2011–2013 Japan Public 34
Tiwari et al. [39] 2016 2004–2014 United States Public 12 4 8
Zack et al. [40] 2017 2004–2013 United States Private 1152 606 546
Elgendy et al. [41] 2019 2012–2014 United States Public 840 479 361
Elsisy et al. [42] 2021 1993–2019 United States Private 134 66 68
Khalid et al. [43] 2022 2012–2019 United States 2205
Weinberg et al. [44] 2022 2012–2019 Australia Public/Private 18 14 4

Risk of bias within the studies

The 28 publications selected for review were all retrospective cohort studies. According to the Scottish Intercollegiate Guideline Network cohort study checklist, no studies were classified as “high-quality” evidence. However, all were deemed to be of “acceptable quality,” because they were based on clear and focused research questions.

Study population

A total of 6411 patients were included in the review, all of whom were ≥90 years of age and underwent CABG, valvular surgery, aortic dissection repair, or a combination thereof (distribution of surgery types in Fig 2). Of the 28 publications selected for review, 19 included patients who underwent a combination of surgical interventions: six focused solely on surgical aortic valve repair, one focused exclusively on CABG, and one focused on repair of type A aortic dissection. Detailed sociodemographic data beyond these descriptors was not provided.

Fig 2. Bubble plot illustrating in-hospital or 30-day mortality rates (%).

Fig 2

Each bubble represents a study, and bubble size corresponds to the number of patients included in the study (as indicated by the color gradient scale).

Cardiopulmonary bypass and aortic clamp times

Whereas 15 publications reported the cardiopulmonary bypass (CPB) time, 13 reported the aortic cross-clamp (ACC) time. The median CPB time was 102 min (range, 60–152 min; IQR, 90–126), whereas the median ACC time was 60 min (range, 45–95 min; IQR 51.7–83.6). The CPB and ACC times in these studies are listed in S3 Table.

Risk stratification scores

Among the 21 studies (77.8%) reporting some form of a risk stratification score, 19 studies (70.4% of total) used the New York Heart Association functional classification, four studies (14.8% of total) used EuroScores, three studies (11.1% of total) used the American Society of Thoracic Surgeons (STS) score, and one study (3.7% of total) used the Charlson Comorbidity Index.

Primary outcomes

Mortality.

All 28 studies evaluated in-hospital or 30-day mortality rates. The median 30-day mortality rate was 10.5% (IQR 7.2–14.6). Nineteen studies also reported longer-term mortality rates. The in-hospital or 30-day mortality rates, together with the corresponding number of patients included in each study are presented graphically in Fig 2. The inpatient, 30-day, 1-year, 2-year, and overall mortality rates are shown in Fig 3. Mortality stratified by each study, together with the types of cardiac surgical procedures performed, is presented in Fig 4.

Fig 3. Box and whisker plots showing inpatient, 30-day, 1-year, 2-year, and overall mortality rates.

Fig 3

The box shows the median and 25th and 75th quartiles. The whiskers represent the minimum and maximum values.

Fig 4. Mortality stratified by each study, together with the types of cardiac surgical procedures performed.

Fig 4

Abbreviations: SAVR, surgical aortic valve replacement; CABG, coronary artery bypass; type AoD, type A aortic dissection repair; mixed, aortic, mitral, or tricuspid valve repair or replacement (or a combination thereof).

Incidence of complications.

Of the 28 (71.4%) studies, 20 reported postoperative complication rates; 3545 patients were included in this group, and the median overall complication rate was 71.4%. The reported complications were grouped into specific categories, including respiratory, cardiac, neurological, gastrointestinal, renal, infectious, arrhythmogenic, and hemorrhagic complications, as well as those requiring insertion of a permanent cardiac pacemaker. Respiratory, cardiac, renal, neurologic (i.e., confusion and disorientation), gastrointestinal, and/or infectious complications were reported in 19%, 20%, 14%, 18%, 5%, and 9% of these patients, respectively. Hemorrhagic and arrhythmogenic complications were reported in 9% and 45% of these patients, respectively, and 10% required pacemaker insertion. The overall complication rates by complication type are presented in S4 Table.

Secondary outcomes

Length of hospital and intensive care unit stay.

Fifteen publications reported the length of hospital stay, whose median was 12.5 days (IQR 10.3–18.0). Nine publications reported the length of ICU stay, whose median was 7.1 days (IQR 3.3–11.5) (S5 Table). No studies reported unplanned ICU readmissions.

Patient-reported experience and outcomes measures.

None of the included studies reported PROMs or PREMs; therefore, this study objective was unmet.

Discussion

As global life expectancy increases, and the nonagenarian population is predicted to exceed 30 million people by 2030 [2], the prevalence of symptomatic coronary and valvular heart diseases continues to increase [5,6]. Although percutaneous and transcatheter interventions are frequently evaluated in this age group, a notable proportion of these patients are not anatomically or technically suited for these procedures. In such cases, traditional cardiac surgery has become the preferred surgical option, regardless of patients’ advanced age. Consequently, the number of nonagenarians considering and undergoing surgical interventions will continue to increase. This scoping review provided a detailed synopsis of the current understanding of the perioperative course, complications, and the effects of these procedures on patients’ quality of life. An accurate understanding of the outcomes experienced by nonagenarians who have undergone cardiac surgery will be crucial for preoperative decision-making and appropriate informed consent [45].

Obtaining informed consent poses a major ethical challenge, particularly in the context of patients with cognitive decline or frailty, because these conditions can impair decisional capacity. Consequently, a nuanced approach is required to carefully balance respect for patient autonomy with the principle of beneficence. Ethical decision-making in this context also requires addressing broader considerations, such as avoiding ageism, ensuring equitable resource allocation, and upholding principles of justice. Central to this process is the use of patient-centered strategies grounded in comprehensive geriatric assessments, which provide a holistic understanding of patients’ medical, functional, and psychosocial needs to guide ethical and equitable care. Effective communication and shared decision-making processes are essential for navigating these complexities, and ensuring that care aligns with patients’ values and preferences while optimizing outcomes. [45,46].

Specific outcomes

Mortality.

Whereas all studies reported in-hospital or 30-day mortality, only 66% included detailed reports of long-term mortality. Overall, the median in-hospital and 30-day mortality rates were below 11%, in agreement with the previously reported mortality rates of 7%–18% [31]. Interestingly, these mortality rates are somewhat lower than the reported rates of approximately 33% for elective cases and as high as 38% for emergency cases among nonagenarians undergoing high-risk non-cardiac surgery [10]. Several factors beyond the statistical methods are likely to have contributed to this counterintuitive finding. First, the stringent patient selection for cardiac surgery in nonagenarians creates a highly selected cohort: patients must demonstrate adequate physiological reserves, cognitive function, and life expectancy to justify the procedural risk. In contrast, non-cardiac surgery populations might include emergent presentations with less rigorous preoperative optimization. Second, the availability of transcatheter alternatives might selectively direct higher-risk nonagenarians away from open surgery. Frail patients might be triaged toward transcatheter aortic valve replacement or medical management, thus further contributing to the lower observed mortality. Third, the reported increase in mortality of nonagenarians undergoing non-cardiac surgery represents a general nonagenarian population rather than a highly selected cardiac-surgery cohort. Fourth, the data reflect predominantly high-income countries with advanced perioperative care systems, specialized cardiac surgery centers, and comprehensive postoperative support.

Although older patients are widely understood to be likely to have poorer surgical outcomes and experience greater morbidity than their younger counterparts, our findings suggest that nonagenarians undergoing cardiac surgery might have lower in-hospital and 30-day mortality rates than nonagenarians undergoing non-cardiac surgery [10]. The apparent reversal might reflect the intersection of careful patient selection, advanced healthcare infrastructure, and the inherent bias in studying only patients deemed suitable for major cardiac surgery. Collectively, the included studies reported a median long-term mortality rate of 43%, and a subset of studies reported an average 5-year mortality rate of 53%. As noted above, long-term mortality data were reported at time points ranging from 1 to 7.5 years. The lack of a uniform definition or method for assessing long-term mortality among nonagenarians undergoing cardiac surgery might create difficulties for anesthetists, physicians, surgeons, and patients seeking to weigh the potential benefits of surgery against the optimal medical management of their cardiovascular disease.

Complications.

Of the 28 publications, 20 reported complications experienced by nonagenarians undergoing cardiac surgery, and revealed a median complication rate of 71%, a value exceeding the 60% reported for major non-cardiac surgery [10]. The most frequently reported complications were arrhythmogenic complications, with an incidence of 45%, similarly to previously published findings [34]. Collectively, these findings suggest that atrial fibrillation occurs more frequently in nonagenarians than in younger patients undergoing cardiac surgery [25]. Although previous studies have highlighted the efficacy of prophylactic antiarrhythmic medications in decreasing postoperative atrial tachycardia in younger cardiac surgical patients, the generalizability of these findings to the nonagenarian population remains unclear [47]. The perioperative administration of these medications was not addressed in any studies included in this review. Moreover, a study published in 2023 by Gaudino et al. [48], including more than 1.2 million patients, has reported a coronary artery bypass grafting complication rate of only 15% among patients 59–73 years of age. Similarly, Bis et al. [49], in a study on postoperative conduction disturbances that included 15,000 patients within a similar age range, have found that permanent pacemaker implantation was required in only 1%–5% of cases. Respiratory, renal, and neurological (e.g., delirium) complications had reported median rates of 19%, 14%, and 18%, respectively. These complications frequently develop in vulnerable surgical populations [50].

The observed elevated complication rates have major implications for surgical decision-making in this cohort. Although advanced age alone should not preclude surgical intervention, the heightened risk of complications and mortality warrants careful consideration. The extant literature has reported postoperative complication rates reaching 60% in nonagenarians undergoing major surgery, and a 1-year mortality rate of approximately 20% after cardiac procedures. These substantial risks necessitate comprehensive discussions with patients and their families to facilitate informed decision-making. Surgeons must carefully balance the potential benefits of surgery against the associated risks, while considering patient preferences and anticipated postoperative quality of life. In assessing surgical candidacy, factors such as frailty, comorbidities, and functional status should be evaluated in conjunction with age. Moreover, the urgency of the procedure is a critical consideration, because elective surgeries generally yield more favorable outcomes than urgent or emergent surgeries. Ultimately, the decision to proceed with cardiac surgery in nonagenarians should be individualized, taking into account not only survival prospects but also the potential for improved functional status and quality of life.

Length of hospital and ICU stay.

ICU admission can have adverse physical, cognitive, and psychological effects on patients, which are frequently referred to as post-intensive care syndrome. This syndrome can lead to significant long-term adverse sequelae for patients undergoing surgery, as well as their families and caregivers [50]. Although the length of ICU stay is directly associated with diminished survival rates and quality of life [51], only five (18%) studies addressed both the length of hospital stay and ICU admission. Of the original 28 publications included in this study, nine (33%) reported the length of ICU admission, and 15 (54%) reported the length of hospital stay. Given the inconsistencies among these reports, the results of cross-study comparisons are unlikely to be highly reliable. The reported median ICU and hospital stays of 7.0 and 12.5 days, respectively, were longer than those previously reported for octogenarians [52]. Better understanding of the factors contributing to these prolonged admissions is needed to improve informed decision-making and optimize the selection of nonagenarians most likely to benefit from surgery.

Quality of life outcome measures and frailty.

Whereas all studies included in this review reported in-hospital or 30-day mortality rates, nearly one-third did not report long-term mortality rates. Less than one-third of the studies included quality-of-life metrics but used inconsistent reporting standards [22]. Furthermore, baseline function and comorbidities were reported in only 18 of the original 28 studies.

Our results revealed a notable scarcity of literature examining the effects of frailty on cardiac surgery outcomes in nonagenarians. Indeed, nonagenarians in relatively poor health might potentially have been steered away from these procedures by physicians, family members, or themselves. Overall, we identified no consistent use of specific frailty scores, and analyses of the effects of frailty on patient outcomes after cardiac surgery were limited. Similarly, long-term age-related health status following major noncardiac surgery remains largely unaddressed. In one small study including 159 octogenarians and nonagenarians who underwent non-cardiac surgery, only 50% of the patients survived for more than 3 years [53]. Whereas our review of recent evidence suggested that good surgical outcomes can be achieved with careful patient selection, and that age alone should not be a barrier to surgery, a previous study has reported that 25% of patients older than 85 years undergoing noncardiac surgery experienced a moderate, severe, or total limitation in functional capacity [54]. Our scoping review revealed a substantial gap in the literature: very few reports have focused specifically on functional outcomes in older patients who have undergone cardiac surgery.

Implications and knowledge gaps

Our review summarized the body of evidence and crucial outcome indicators and shed light on the unique challenges faced by nonagenarians after cardiac surgery. Collectively, our findings underscored that age alone should not be a disqualifying factor for surgery. With careful selection, this patient group experiences a relatively low perioperative 30-day mortality rate, thus highlighting the importance of considering postoperative complications and prolonged ICU stays. Although we extracted elective versus emergency classification, when provided, the reporting was inconsistent; therefore, improved standardization is warranted in future research. Whereas the 1-year mortality rate was approximately 20%, the lack of PROM and PREM data suggested that post-surgical quality of life remains largely undetermined.

This review emphasizes the need to standardize complication grading and reporting in cardiac surgery for nonagenarians (Table 3). The findings also highlight the need for prospective trials and reviews of international registry data to identify risk factors associated with adverse outcomes in nonagenarians, explore potential measures to decrease the risk of severe complications, and improve the quality of life after surgery.

Table 3. Recommended minimum standards for reporting on nonagenarians undergoing cardiac surgery.

Preoperative Intraoperative Postoperative
• Anthropometrics: weight, height, body mass index
• Residential status: home, residential care facility, level of dependence
• Rurality and socio-economic status
• Frailty score [55]
• Comorbidities
• EuroSCORE II
• Assessment for cognitive impairment and dementia [56]
• Echocardiographic findings: ventricular function, pulmonary artery pressures
• Time from hospital admission to surgery
• Blood tests: hemoglobin, creatinine, albumin, fibrinogen, coagulation, ferritin, troponin (mmol/L), B-type natriuretic peptide (pg/mL)
• Surgery category: elective, urgent, emergent
• Type of surgery
• Cardiopulmonary bypass time
• Cross-clamp time
• Use of blood or blood products
• Need for vasoactive medication and inotropes
• Need for intraoperative mechanical support
• Duration of mechanical ventilation
• Duration of epicardial pacing time
• Use of blood or blood products
• Return to operating theater
• Standardized definitions of postoperative complications [57,58] graded according to Clavien-Dindo [59] classification
    - Acute kidney injury
    - New atrial fibrillation and/or atrial flutter
    - Delirium
    - Pulmonary complications [60]
    - Stroke
    - Surgical site infection
    - Return to operating theatre and reason
    - Heart block and/or bradycardia requiring pacemaker
    - In-hospital mortality
    - Unexpected readmission to ICU
    - Hemoglobin and creatinine values on hospital discharge
• Discharge destination: home or rehabilitation facility
• Quality of recovery scores [60,61]
• Postoperative morbidity survey [6264]
• Stroke within 30 days of surgery
• Days alive and at home, as many as 30, 90 or 180 days after surgery [6568]
• Unplanned hospital readmissions
• Patient-reported outcome measures (PROMs) [6869]
• Patient-reported experience measure (PREMs) [70]
• Health economic measures

Strengths and limitations

This review has several notable strengths. First, it provided a comprehensive analysis of mortality and complication rates in nonagenarians undergoing cardiac surgery, thereby offering valuable insights into the outcomes associated with these high-risk procedures. Additionally, the findings underscored critical gaps in the current literature and suggested several directions for future research that might enhance understanding of the postoperative trajectory in nonagenarian patients. Such advancements might potentially inform clinical decision-making and optimize care strategies for this vulnerable population. The findings might also be used to facilitate informed preoperative discussions and decision-making by physicians, surgeons, anesthetists, and, most importantly, patients and their families.

This review has several limitations. First, patient-level data were not reported in many of the included studies. Therefore, analyses could be performed only on reported population data, which provided no insights into specific pre-existing comorbidities, frailty, or the urgency of surgical intervention. Unfortunately, most included studies did not stratify outcomes by surgical urgency, thus constraining our ability to evaluate the differential effects of elective vs. emergent procedures. Furthermore, although we collected data reported for 6411 nonagenarians included in 28 publications, two studies [40,43] performed in the past 2–6 years accounted for more than half of those patients, and included those most likely to benefit from the most recent developments in this field. We acknowledge that the patients included in our review from The Society of Thoracic Surgeons National Database [23] might overlap with patients in the nine other studies included in this review. This potential crossover is an important consideration in interpreting our findings. However, after exclusion of these studies from the analysis, our results were unchanged. This finding further highlights the need for future research to more precisely quantify the extent of patient overlap in multi-center cardiac surgery studies. Third, because of the apparent heterogeneity in comorbidity and functional status, we were unable to generate strong conclusions regarding preoperative status and its potential effects on postoperative outcomes and quality of life. Because no sociodemographic data were available, the generalizability of our findings across sexes, ethnicities, regions, and countries of origin remains unclear.

Finally, we acknowledge that a substantial proportion of the articles included in our analysis were older than 10 years and consequently might not fully reflect current medical practices, particularly given the increasing prominence of endovascular procedures in treating nonagenarian patients across various cardiovascular domains, including structural valve pathology. However, the included studies provide historical context and insight into the evolution of cardiac surgery in nonagenarians; highlight advancements and shifts in treatment paradigms over time; and offer a broader perspective on long-term outcomes and complications, which are crucial for understanding the durability and effectiveness of interventions. Finally, our findings cannot be generalized to lower-resource settings or lower- and middle-income countries, where risk profiles and outcomes may differ significantly.

Ethical tensions, individual benefits, and resource allocation

Providing open cardiac surgery to nonagenarians presents complex health economic and ethical challenges, particularly in resource-constrained settings and lower- and middle-income countries, where healthcare systems often operate with limited capacity and funding. The cost of cardiac surgery is substantial, and prolonged ICU stays, increased complication rates, and extended hospital admissions are often involved, thereby contributing to higher healthcare expenditures than required for younger cohorts. Moreover, in lower- and middle-income countries, where access to expensive interventions must be weighed against broader public health needs, questions arise regarding whether prioritizing high-cost procedures in the oldest populations constitutes an equitable or sustainable use of limited resources. Consequently, tension exists between the ethical principle of individual beneficence, providing the best possible care to a single patient, and the utilitarian imperative to maximize health outcomes at the population level. Ivashkov and Van Norman have argued that surgical decision-making in older adults must balance respect for autonomy with realistic expectations of benefit and resource stewardship, particularly when quality of life might be diminished by frailty, comorbidities, or cognitive impairment [71]. Similarly, Altawalbeh et al. have highlighted how age-related ethical frameworks must incorporate considerations of distributive justice, given that the opportunity cost of providing intensive treatment to nonagenarians might result in denying care to younger or more functionally independent patients [46]. Because surgical outcomes in the oldest populations remain highly variable, and data on long-term functional recovery remain sparse, healthcare policymakers must increasingly confront the moral dilemma of whether aggressive interventions are justifiable when life expectancy and quality-adjusted life years might be limited. Accordingly, transparent, culturally sensitive, and evidence-informed triage frameworks are essential to support ethical and economically sound decision-making in cardiac surgery for the oldest populations. As demographics shift globally, policies must reconcile economic realism with ethical imperatives to avoid discriminatory rationing, and must uphold the “fair innings” principle aimed at equitable health opportunities across lifespans [72,73].

Future directions

This scoping review highlights several important avenues for future research. Among these, establishing a standard time point for assessing long-term mortality, and applying and validating objective pre- and postoperative functional status and quality-of-life metrics, might be beneficial [74,75]. Such initiatives stand to greatly improve understanding of the short- and long-term effects of cardiac surgery in nonagenarian populations beyond immediate survival and complication rates.

Creating and implementing uniform preoperative frailty assessments, and correlating them with surgical outcomes, will also be crucial. Assessments should include preoperative residential status, hospital discharge destination, and independence in activities of daily living 12 months post-cardiac surgery. In addition, the development of standardized PROMs and PREMs tailored to nonagenarians is imperative. These tools provide healthcare providers with essential data to evaluate the cost-effectiveness of surgical interventions in terms of quality-adjusted life years, thereby offering a common value currency for comparing different disease states [76].

Future research should prioritize investigating the specific effects of individual cardiac procedures, particularly in nonagenarian populations, to provide more nuanced insights beyond the aggregated outcomes of all open cardiac interventions. Such studies would offer valuable evidence to support informed decision-making tailored to this unique demographic. Additionally, the effects of cardiac surgery on functional status and quality of life are critical areas for further exploration, because these outcomes are central to patient-centered care. Leveraging data from large national registry databases, such as SWEDEHEART [77], presents opportunities to expand upon existing findings, and generate robust evidence to inform clinical practice and policy.

Finally, the findings presented in this review might assist cardiac surgeons, anesthetists, and perioperative clinicians in assessing both the quantifiable risks and functional unknowns of cardiac surgery, and further provide patients and their families with critical information to guide discussions focused on the benefits and risks of proceeding with cardiac surgery or seeking alternative management strategies.

Conclusions

This scoping review highlights that, although age alone should not be a barrier to cardiac surgery for nonagenarians, this surgery is associated with significantly elevated morbidity and a relatively high mortality rate. Notably, among patients in this age range, one in ten die, and two-thirds of patients succumb to complications within 30 days post-surgery. Most of these patients experience extended intensive care stays. Despite these challenges, most of these patients are ultimately discharged from the hospital. A critical gap in the literature is the scarcity of data on quality-of-life measures and patient-reported outcomes, which are essential for informed clinical discussions and consent. Incorporating these factors into decision-making processes will be crucial to ensure that care aligns with patients’ values and preferences, particularly in this vulnerable population. Future research should prioritize the collection and analysis of these outcomes to enhance the quality and relevance of care for nonagenarians undergoing cardiac surgery.

Our review highlights major gaps in the collective knowledge base and specific areas requiring further research, including standardized methods for reporting complications, patient-centered outcomes, functional recovery metrics, and long-term mortality data. Addressing these gaps would enhance understanding of patient selection criteria, as well as the perioperative and postoperative experiences of nonagenarians undergoing cardiac surgery.

Supporting information

S1 Table. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist.

(DOCX)

pone.0331755.s001.docx (47.5KB, docx)
S2 Table. Full search strategies for all electronic databases.

(DOCX)

pone.0331755.s002.docx (18.5KB, docx)
S3 Table. Cardiopulmonary bypass and aortic cross-clamp: times reported by the publications included in the review.

(DOCX)

pone.0331755.s003.docx (18.5KB, docx)
S4 Table. Overall complication rates listed by type.

(DOCX)

pone.0331755.s004.docx (17.7KB, docx)
S5 Table. Length of hospital and intensive care stay.

(DOCX)

pone.0331755.s005.docx (17.2KB, docx)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

Guarantor

Prof. Laurence Weinberg is the guarantor.

References

  • 1.Life expectancy of the world population. Available from: https://www.worldometers.info/demographics/life-expectancy/
  • 2.United Nations. Revision of World Population Prospects. Available from: https://population.un.org/wpp/
  • 3.Sagiv D, Migirov L, Lipschitz N, Dagan E, Glikson E, Wolf M, et al. The admission patterns of octogenerians nonagenerians and centenarians to the Department of Otoloaryngology. Eur Arch Otorhinolaryngol. 2016;273(12):4615–21. doi: 10.1007/s00405-016-4165-4 [DOI] [PubMed] [Google Scholar]
  • 4.Nicolini F, Agostinelli A, Vezzani A, Manca T, Benassi F, Molardi A, et al. The evolution of cardiovascular surgery in elderly patient: a review of current options and outcomes. Biomed Res Int. 2014;2014:736298. doi: 10.1155/2014/736298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Friedrich I, Simm A, Kötting J, Thölen F, Fischer B, Silber R-E. Cardiac surgery in the elderly patient. Dtsch Arztebl Int. 2009;106(25):416–22. doi: 10.3238/arztebl.2009.0416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.van Bemmel T, Delgado V, Bax JJ, Gussekloo J, Blauw GJ, Westendorp RG, et al. Impact of valvular heart disease on activities of daily living of nonagenarians: the Leiden 85-plus study a population based study. BMC Geriatr. 2010;10:17. doi: 10.1186/1471-2318-10-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kodali SK, Velagapudi P, Hahn RT, Abbott D, Leon MB. Valvular heart disease in patients ≥80 years of age. Journal of the American College of Cardiology. 2018. May;71(18):2058–72. doi: 10.1016/j.jacc.2018.03.459 [DOI] [PubMed] [Google Scholar]
  • 8.Narendren A, Whitehead N, Burrell LM, Yudi MB, Yeoh J, Jones N, et al. Management of Acute Coronary Syndromes in Older People: Comprehensive Review and Multidisciplinary Practice-Based Recommendations. J Clin Med. 2024;13(15):4416. doi: 10.3390/jcm13154416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ogawa T, Schermann H, Kobayashi H, Fushimi K, Okawa A, Jinno T. Age and clinical outcomes after hip fracture surgery: do octogenarian, nonagenarian and centenarian classifications matter? Age Ageing. 2021;50(6):1952–60. doi: 10.1093/ageing/afab137 [DOI] [PubMed] [Google Scholar]
  • 10.Fowler AJ, Abbott TEF, Prowle J, Pearse RM. Age of patients undergoing surgery. Br J Surg. 2019;106(8):1012–8. doi: 10.1002/bjs.11148 [DOI] [PubMed] [Google Scholar]
  • 11.Watters JM. Surgery in the elderly. Can J Surg. 2002;45(2):104–8. [PMC free article] [PubMed] [Google Scholar]
  • 12.Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73. doi: 10.7326/M18-0850 [DOI] [PubMed] [Google Scholar]
  • 13.Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Social Research Methodology. 2005;8(1):19–32. doi: 10.1080/1364557032000119616 [DOI] [Google Scholar]
  • 14.Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69. doi: 10.1186/1748-5908-5-69 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ludski J, Carp B, Makar T, Yii M, Lee D-K, Weinberg L. Outcomes and complications of nonagenarians undergoing cardiac surgery: a scoping review protocol. BMJ Open. 2023;13(7):e072293. doi: 10.1136/bmjopen-2023-072293 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dobrescu AI, Nussbaumer-Streit B, Klerings I, Wagner G, Persad E, Sommer I, et al. Restricting evidence syntheses of interventions to English-language publications is a viable methodological shortcut for most medical topics: a systematic review. J Clin Epidemiol. 2021;137:209–17. doi: 10.1016/j.jclinepi.2021.04.012 [DOI] [PubMed] [Google Scholar]
  • 17.Tsai TP, Denton TA, Chaux A, Matloff JM, Kass RM, Blanche C, et al. Results of coronary artery bypass grafting and/or aortic or mitral valve operation in patients > or = 90 years of age. Am J Cardiol. 1994;74(9):960–2. doi: 10.1016/0002-9149(94)90599-1 [DOI] [PubMed] [Google Scholar]
  • 18.Samuels LE, Sharma S, Morris RJ, Kuretu ML, Grunewald KE, Strong MD 3rd, et al. Cardiac surgery in nonagenarians. J Card Surg. 1996;11(2):121–7. doi: 10.1111/j.1540-8191.1996.tb00025.x [DOI] [PubMed] [Google Scholar]
  • 19.Blanche C, Matloff JM, Denton TA, Khan SS, DeRobertis MA, Nessim S, et al. Cardiac operations in patients 90 years of age and older. Ann Thorac Surg. 1997;63(6):1685–90. doi: 10.1016/s0003-4975(97)00091-x [DOI] [PubMed] [Google Scholar]
  • 20.Miller DJ, Samuels LE, Kaufman MS, Morris RJ, Thomas MP, Brockman SK. Coronary artery bypass surgery in nonagenarians. Angiology. 1999;50(8):613–7. doi: 10.1177/000331979905000801 [DOI] [PubMed] [Google Scholar]
  • 21.Bacchetta MD, Ko W, Girardi LN, Mack CA, Krieger KH, Isom OW, et al. Outcomes of cardiac surgery in nonagenarians: a 10-year experience. Ann Thorac Surg. 2003;75(4):1215–20. doi: 10.1016/s0003-4975(02)04666-0 [DOI] [PubMed] [Google Scholar]
  • 22.Bridges CR, Edwards FH, Peterson ED, Coombs LP, Ferguson TB. Cardiac surgery in nonagenarians and centenarians. J Am Coll Surg. 2003;197(3):347–56; discussion 356-7. doi: 10.1016/S1072-7515(03)00384-3 [DOI] [PubMed] [Google Scholar]
  • 23.Edwards M-B, Taylor KM. Outcomes in nonagenarians after heart valve replacement operation. The Annals of Thoracic Surgery. 2003. ;75(3):830–4. doi: 10.1016/s0003-4975(02)04558-7 [DOI] [PubMed] [Google Scholar]
  • 24.Levy Praschker BG, Leprince P, Bonnet N, Rama A, Bors V, Lievre L, et al. Cardiac surgery in nonagenarians: hospital mortality and long-term follow-up. Interact Cardiovasc Thorac Surg. 2006;5(6):696–9. doi: 10.1510/icvts.2006.138255 [DOI] [PubMed] [Google Scholar]
  • 25.Roberts WC, Ko JM, Matter GJ. Aortic valve replacement for aortic stenosis in nonagenarians. Am J Cardiol. 2006;98(9):1251–3. doi: 10.1016/j.amjcard.2006.05.061 [DOI] [PubMed] [Google Scholar]
  • 26.Hovanesyan A, Moon MR, Rich MW. Cardiac surgery in nonagenarians. J Cardiovasc Surg (Torino). 2007;48(6):757–60. [PubMed] [Google Scholar]
  • 27.Guilfoyle MR, Drain AJ, Khan A, Ferguson J, Large SR, Nashef SAM. Cardiac surgery in nonagenarians: single-centre series and review. Gerontology. 2010;56(4):378–84. doi: 10.1159/000271602 [DOI] [PubMed] [Google Scholar]
  • 28.Ullery BW, Peterson JC, Milla F, Wells MT, Briggs W, Girardi LN, et al. Cardiac surgery in select nonagenarians: should we or shouldn’t we? Ann Thorac Surg. 2008;85(3):854–60. doi: 10.1016/j.athoracsur.2007.10.074 [DOI] [PubMed] [Google Scholar]
  • 29.Hajabed H, Rezk A, Ouda W, Gallo R. Cardiac surgery in nonagenarian. Should we operate? Interactive Cardiovascular and Thoracic Surgery 2010;10:s152–s153. doi: 10.1510/icvts.2010.0000S1 [DOI] [Google Scholar]
  • 30.Speziale G, Nasso G, Barattoni MC, Bonifazi R, Esposito G, Coppola R, et al. Operative and middle-term results of cardiac surgery in nonagenarians. Circulation. 2010. Jan 19;121(2):208–13. doi: 10.1161/CIRCULATIONAHA.108.807065 [DOI] [PubMed] [Google Scholar]
  • 31.Easo J, Hölzl PPF, Horst M, Dikov V, Litmathe J, Dapunt O. Cardiac surgery in nonagenarians: pushing the boundary one further decade. Arch Gerontol Geriatr. 2011;53(2):229–32. doi: 10.1016/j.archger.2010.11.026 [DOI] [PubMed] [Google Scholar]
  • 32.Assmann A, Minol J-P, Mehdiani A, Akhyari P, Boeken U, Lichtenberg A. Cardiac surgery in nonagenarians: Not only feasible, but also reasonable? Interactive CardioVascular and Thoracic Surgery. 2013. ;17(2):340–3. doi: 10.1093/icvts/ivt125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Caceres M, Cheng W, De Robertis M, Mirocha JM, Czer L, Esmailian F, et al. Survival and quality of life for Nonagenarians after cardiac surgery. The Annals of Thoracic Surgery. 2013;95(5):1598–602. doi: 10.1016/j.athoracsur.2013.02.034 [DOI] [PubMed] [Google Scholar]
  • 34.Davis JP, LaPar DJ, Crosby IK, Kern JA, Lau CL, Kron IL, et al. Nonagenarians undergoing cardiac surgery. J Card Surg. 2014;29(5):600–4. doi: 10.1111/jocs.12391 [DOI] [PubMed] [Google Scholar]
  • 35.Murashita T, Greason KL, Suri RM, Nkomo VT, Holmes DR, Rihal CS, et al. Aortic valve replacement for severe aortic valve stenosis in the nonagenarian patient. The Annals of Thoracic Surgery. 2014. ;98(5):1593–7. doi: 10.1016/j.athoracsur.2014.06.015 [DOI] [PubMed] [Google Scholar]
  • 36.Mack MC, Szerlip M, Herbert MA, Akram S, Worley C, Kim RJ, et al. Outcomes of Treatment of Nonagenarians With Severe Aortic Stenosis. Ann Thorac Surg. 2015;100(1):74–80. doi: 10.1016/j.athoracsur.2015.02.045 [DOI] [PubMed] [Google Scholar]
  • 37.George I, Yerebakan H, Kalesan B, Nazif T, Kodali S, Smith CR, et al. Age alone should not preclude surgery: Contemporary outcomes after aortic valve replacement in nonagenarians. The Journal of Thoracic and Cardiovascular Surgery. 2014;148(4). doi: 10.1016/j.jtcvs.2014.01.015 [DOI] [PubMed] [Google Scholar]
  • 38.Ohnuma T, Shinjo D, Fushimi K. Hospital mortality of patients aged 80 and older after surgical repair for type A acute aortic dissection in Japan. Medicine (Baltimore). 2016;95(31):e4408. doi: 10.1097/MD.0000000000004408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Tiwari A, Gupta A, Subzposh F, McCaffrey J, Koman E, Saltzman H, et al. Outcomes of transvenous lead extraction in nonagenarians. J Am Coll Cardiology. 2016;67(13):816. doi: 10.1016/s0735-1097(16)30817-8 [DOI] [Google Scholar]
  • 40.Zack CJ, Al-Qahtani F, Kawsara A, Al-Hijji M, Amin AH, Alkhouli M. Comparative Outcomes of Surgical and Transcatheter Aortic Valve Replacement for Aortic Stenosis in Nonagenarians. Am J Cardiol. 2017;119(6):893–9. doi: 10.1016/j.amjcard.2016.11.045 [DOI] [PubMed] [Google Scholar]
  • 41.Elgendy IY, Mahmoud AN, Elbadawi A, Elgendy AY, Omer MA, Megaly M, et al. In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians. Catheter Cardiovasc Interv. 2019;93(5):989–95. doi: 10.1002/ccd.28050 [DOI] [PubMed] [Google Scholar]
  • 42.Elsisy MF, Schaff HV, Crestanello JA, Alkhouli MA, Stulak JM, Stephens EH. Outcomes of cardiac surgery in nonagenarians. J Card Surg. 2022;37(6):1664–70. doi: 10.1111/jocs.16396 [DOI] [PubMed] [Google Scholar]
  • 43.Khalid Y, Khalid F, Dasu K, Dasu N. TCT-495 Insights From the National Inpatient Sample 2012 to 2019: Comparing SAVR vs TAVR Outcomes in Nonagenarians and Centenarians. Journal of the American College of Cardiology. 2022;80(12):B201. doi: 10.1016/j.jacc.2022.08.584 [DOI] [Google Scholar]
  • 44.Weinberg L, Walpole D, Lee DK, D’Silva M, Chan JW, Miles LF, et al. Modern Cardiac Surgical Outcomes in Nonagenarians: A Multicentre Retrospective Observational Study. Front Cardiovasc Med. 2022;9:865008. doi: 10.3389/fcvm.2022.865008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ivashkov Y, Van Norman GA. Informed consent and the ethical management of the older patient. Anesthesiology Clinics. 2009;27: 569–580. doi: 10.1016/j.anclin.2009.07.016 [DOI] [PubMed] [Google Scholar]
  • 46.Altawalbeh SM, Alkhateeb FM, Attarabeen OF. Ethical issues in consenting older adults.Altawalbeh SM, Alkhateeb FM, Attarabeen OF. Ethical Issues in Consenting Older Adults: Academic Researchers and Community Perspectives. J Pharm Health Serv Res. 2020;11(1):25–32. doi: 10.1111/jphs.12327 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Mitchell LB, Exner DV, Wyse DG, Connolly CJ, Prystai GD, Bayes AJ, et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. JAMA. 2005;294(24):3093–100. doi: 10.1001/jama.294.24.3093 [DOI] [PubMed] [Google Scholar]
  • 48.Gaudino M, Chadow D, Rahouma M, Soletti GJ, Sandner S, Perezgrovas-Olaria R, et al. Operative Outcomes of Women Undergoing Coronary Artery Bypass Surgery in the US, 2011 to 2020. JAMA Surg. 2023;158(5):494–502. doi: 10.1001/jamasurg.2022.8156 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Bis J, Gościńska-Bis K, Gołba KS, Gocoł R, Zębalski M, Deja MA. Permanent pacemaker implantation after cardiac surgery: Optimization of the decision making process. J Thorac Cardiovasc Surg. 2021;162(3):816–824.e3. doi: 10.1016/j.jtcvs.2020.01.082 [DOI] [PubMed] [Google Scholar]
  • 50.Morgan A. Long-term outcomes from critical care. Surgery (Oxford). 2021;39(1):53–7. doi: 10.1016/j.mpsur.2020.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Widyastuti Y, Stenseth R, Wahba A, Pleym H, Videm V. Length of intensive care unit stay following cardiac surgery: is it impossible to find a universal prediction model?. Interact Cardiovasc Thorac Surg. 2012;15(5):825–32. doi: 10.1093/icvts/ivs302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Scott BH, Seifert FC, Grimson R, Glass PSA. Octogenarians undergoing coronary artery bypass graft surgery: resource utilization, postoperative mortality, and morbidity. J Cardiothorac Vasc Anesth. 2005;19(5):583–8. doi: 10.1053/j.jvca.2005.03.030 [DOI] [PubMed] [Google Scholar]
  • 53.Gazala S, Tul Y, Wagg A, Widder SL, Khadaroo RG, Acute Care and Emergency Surgery (ACES) Group. Quality of life and long-term outcomes of octo- and nonagenarians following acute care surgery: a cross sectional study. World J Emerg Surg. 2013;8(1):23. doi: 10.1186/1749-7922-8-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Canada Division of Aging and Seniors Health. Canada’s Aging Population. Ottawa, Canada: Minister of Public Works and Government Services. 2002. [Google Scholar]
  • 55.Howell SJ, Nair S. Measuring frailty in the older surgical patient: The case for evidence synthesis. British Journal of Anaesthesia. 2021;126(4):763–7. doi: 10.1016/j.bja.2021.01.002 [DOI] [PubMed] [Google Scholar]
  • 56.Hasan TF, Kelley RE, Cornett EM, Urman RD, Kaye AD. Cognitive impairment assessment and interventions to optimize surgical patient outcomes. Best Practice & Research Clinical Anaesthesiology. 2020;34(2):225–53. doi: 10.1016/j.bpa.2020.05.005 [DOI] [PubMed] [Google Scholar]
  • 57.Haller G, Bampoe S, Cook T, Fleisher LA, Grocott MPW, Neuman M, et al. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine initiative: clinical indicators. Br J Anaesth. 2019;123(2):228–37. doi: 10.1016/j.bja.2019.04.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol. 2015;32(2):88–105. doi: 10.1097/EJA.0000000000000118 [DOI] [PubMed] [Google Scholar]
  • 59.Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13. doi: 10.1097/01.sla.0000133083.54934.ae [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Abbott TEF, Fowler AJ, Pelosi P, Gama de Abreu M, Møller AM, Canet J, et al. A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications. Br J Anaesth. 2018;120(5):1066–79. doi: 10.1016/j.bja.2018.02.007 [DOI] [PubMed] [Google Scholar]
  • 61.Myles PS, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000;84(1):11–5. doi: 10.1093/oxfordjournals.bja.a013366 [DOI] [PubMed] [Google Scholar]
  • 62.Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score. Anesthesiology. 2013;118(6):1332–40. doi: 10.1097/ALN.0b013e318289b84b [DOI] [PubMed] [Google Scholar]
  • 63.Bennett-Guerrero E, Welsby I, Dunn TJ, Young LR, Wahl TA, Diers TL, et al. The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. Anesth Analg. 1999;89(2):514–9. doi: 10.1097/00000539-199908000-00050 [DOI] [PubMed] [Google Scholar]
  • 64.Grocott MPW, Browne JP, Van der Meulen J, Matejowsky C, Mutch M, Hamilton MA, et al. The Postoperative Morbidity Survey was validated and used to describe morbidity after major surgery. J Clin Epidemiol. 2007;60(9):919–28. doi: 10.1016/j.jclinepi.2006.12.003 [DOI] [PubMed] [Google Scholar]
  • 65.Bell M, Eriksson LI, Svensson T, Hallqvist L, Granath F, Reilly J, et al. Days at Home after Surgery: An Integrated and Efficient Outcome Measure for Clinical Trials and Quality Assurance. EClinicalMedicine. 2019;11:18–26. doi: 10.1016/j.eclinm.2019.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Myles PS, Shulman MA, Heritier S, Wallace S, McIlroy DR, McCluskey S, et al. Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia. BMJ Open. 2017;7(8):e015828. doi: 10.1136/bmjopen-2017-015828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Jerath A, Austin PC, Wijeysundera DN. Days Alive and Out of Hospital: Validation of a Patient-centered Outcome for Perioperative Medicine. Anesthesiology. 2019;131(1):84–93. doi: 10.1097/ALN.0000000000002701 [DOI] [PubMed] [Google Scholar]
  • 68.Shulman MA, Myles PS, Chan MTV, McIlroy DR, Wallace S, Ponsford J. Measurement of disability-free survival after surgery. Anesthesiology. 2015;122(3):524–36. doi: 10.1097/ALN.0000000000000586 [DOI] [PubMed] [Google Scholar]
  • 69.Andrews G, Kemp A, Sunderland M, Von Korff M, Ustun TB. Normative data for the 12 item WHO Disability Assessment Schedule 2.0. PLoS One. 2009;4(12):e8343. doi: 10.1371/journal.pone.0008343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Kingsley C, Patel S. Patient-reported outcome measures and patient-reported experience measures. BJA Education. 2017;17(4):137–44. doi: 10.1093/bjaed/mkw060 [DOI] [Google Scholar]
  • 71.Ivashkov Y, Van Norman GA. Informed consent and the ethical management of the older patient. Anesthesiol Clin. 2009;27(3):569–80, table of contents. doi: 10.1016/j.anclin.2009.07.016 [DOI] [PubMed] [Google Scholar]
  • 72.Kuylen MNI, Kim SY, Ruck Keene A, Owen GS. Should age matter in COVID-19 triage? A deliberative study. J Med Ethics. 2021;47(5):291–5. doi: 10.1136/medethics-2020-107071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Oehring D, Gunasekera P. Ethical Frameworks and Global Health: A Narrative Review of the “Leave No One Behind” Principle. Inquiry. 2024;61:469580241288346. doi: 10.1177/00469580241288346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Lin S-Y, Kerse N, McLean C, Moyes SA. Validation of quality of life and functional measures for older people for telephone administration. J Prim Health Care. 2010;2(1):35–42. doi: 10.1071/hc10035 [DOI] [PubMed] [Google Scholar]
  • 75.Rahman IA, Kendall S. Cardiac surgery in the very elderly: it isn’t all about survival. Br J Cardiol. 2020;27(1):05. doi: 10.5837/bjc.2020.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5–21. doi: 10.1093/bmb/ldq033 [DOI] [PubMed] [Google Scholar]
  • 77.Bäck M, Leosdottir M, Hagström E, Norhammar A, Hag E, Jernberg T, et al. The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry). Eur Heart J Qual Care Clin Outcomes. 2021;7(5):431–7. doi: 10.1093/ehjqcco/qcab039 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Marcelo Arruda Nakazone

13 Nov 2024

Dear Dr. Weinberg,

ACADEMIC EDITOR:

While the manuscript demonstrates significant potential, it requires major revisions and further refinement to meet the standards necessary for publication.

The subject matter is undoubtedly of interest; however, the reviewers have raised critical concerns that must be thoroughly addressed by the authors.

plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Marcelo Arruda Nakazone, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

https://bmjopen.bmj.com/content/13/7/e072293.full

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

3. We note that there is identifying data in the Supporting Information file <Supplementary Table 2 .docx>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws.

Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared:

-Name, initials, physical address

-Ages more specific than whole numbers

-Internet protocol (IP) address

-Specific dates (birth dates, death dates, examination dates, etc.)

-Contact information such as phone number or email address

-Location data

-ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order)

Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants.

Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data ) and in the following article: http://www.bmj.com/content/340/bmj.c181.long .

Please remove or anonymize all personal information (Name/Initials), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: N/A

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

Reviewer #1: This systematic review on outcomes and complications in nonagenarians undergoing cardiac surgery addresses a relevant and timely topic. It provides important insights into mortality rates, complications, and hospital stays in this age group. However, there are several areas where the manuscript could be improved.

Strengths:

The topic is highly pertinent given the aging population and increasing number of elderly surgical candidates. The literature search is thorough, covering multiple countries and procedures. PRISMA guidelines were followed.

Minor Concerns:

The introduction could be streamlined to focus more on the specific gaps in the literature that this review addresses.

The rationale for excluding non-English articles and certain cardiac procedures could be more clearly explained, as this may limit the generalizability of findings. The statistical methods are not adequately described. More detail on data synthesis and analysis, particularly handling of heterogeneity (if any) among studies, is needed. The statistical methods used for data synthesis may be described in more detail. While the manuscript mentions the use of descriptive statistics, there is a lack of detail on how these were calculated and whether any meta-analytic techniques were applied. The authors could consider providing a more robust analysis or explaining why certain methods (e.g. meta-analysis) were not feasible.

The discussion should more critically evaluate the findings, particularly the high complication rates, and offer a more balanced view on surgical risks and benefits. For example, the implications of the high complication rates could be explored in greater depth, particularly concerning how these might influence surgical decision-making in nonagenarians. The manuscript suggests that age should not be a disqualifying factor for surgery, which is an important point. However, this statement would benefit from a discussion of the balance between risks and benefits, considering patient preferences and quality of life post-surgery.

The manuscript identifies a lack of patient-reported outcomes but could suggest how future research might address this gap.

There are a few typographical errors and grammatical issues throughout the manuscript. A thorough proofreading would be beneficial. For example, the sentence "From the initial 1015 articles searched, we included twenty-eight studies from eight countries were included" is redundant and should be revised for clarity.

Ethical Considerations:

A discussion of the ethical implications of surgery in nonagenarians, particularly around informed consent, would be valuable.

Reviewer #2: 1. The authors have to make a choice between a systematic and a scoping review that they seem to assimilate (even in title) but which are two different type of studies with different aim and methodology.

Munn, Z., Peters, M.D.J., Stern, C. et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol 18, 143 (2018). https://doi.org/10.1186/s12874-018-0611-x.

2. One strength of the study is the extended review of literature and the rigorous methodology deployed to perform the analysis since out of 1015 articles searches (with no restriction on study design or date of publication), the authors included 28 studies from 8 countries (most of them issued from US centers) and totalizing a sample size of 6411 patients.

However, the majority of those papers are older than 10 years and certainly do not reflect medical practice in the current era where endovascular procedures has become the main treatment carrier in nonagenarian patients in all domains of cardiovascular diseases including structural valve pathology. Those papers totalize 17% of the overall population but it is not specified how did the authors ensure that patients included in the more recent studies of Khalid, Zack and Elgendy, did not already appear in previous published studies from US. Therefore, in the current review, the probability for one patient to have been reported at least twice is significant.

3. Since a scoping review focuses on the importance of one specified subject in the literature, it is expected that the outcome would relate on one bibliometric index such as the annual incidence of papers related to the subject under study. Instead the authors have used traditional clinical outcomes such as in-hospital mortality, morbidity and length of stay. It even appears that they may have discarded some relevant papers which did not included those clinical outcomes. This is deeply confounding. If they authors aim to perform a systematic review or a metanalysis of the clinical outcomes of cardiac surgery in nonagenarian patients, then the title must be changed as well as the paper has to be deeply revised accordingly.

4. The discussion and interpretation reflect more the author’s belief than the result that they present. Based on those results I would rather assume that the relatively seldom number of papers found in the literature concerning cardiac surgery in nonagenarian patients is a marker of the reluctance to propose chest opening and CPB to frail patients with limited life expectancy. Most of them would probably deny it anyway unless they have the feeling of an imminent death or, most likely, even though. If the well-looking conclusion (not to deny cardiac surgery because of patient’s age only) seems quite reasonable, it is hardly supported by the presented results for a 10% mortality rate for elective procedures is not deemed acceptable in today standards of cardiac surgery.

Reviewer #3: The authors present a scoping review of the literature to look at the outcomes of cardiac surgery in nonagenarians. They have published their protocol and registered the review. The standard of English is generally good although there are scattered typos and grammatical errors that require a thorough check through the paper (e.g. line 138, redundant "The"s). The following comments are designed to help the authors address some conflicts between protocol and paper.

1. There is differing definitions of the Population. In some sections, it is >90y, in others 90-99. Clarify which - and in cases where papers presented mixed data, how this was resolved

2. The paper suggests it will include grey literature, but largely excludes by design the large national registries that might describe this information (e.g., although outside the search dates, the SWEDEHEART registry of nonagenarians published recently)

3. Line 148 - please clarify, were full papers translated?

4. Line 151 - please clarify, this sentence is ambiguous

5. Line 156 - centenarians included here

6. Line 159 - lots of procedures not in the search criteria

7. Information sources are not outlined as per PRISMA giuidelines - how were authors contacted etc

8. Line 193 - not clear how two reviewers can agree on four and five studies and end with nine studies? Surely agreement would mean including just four studies (and one that was not independently agreed on)

9. Line 239 - PPI is possible even in reviews

10. Ref 23 - this large study from the STS database likely crosses over some of the patients from the other studies. How did the authors account for this?

11. Line 274 - Figure 2 does not show operations, but this information would be useful and is not shown elsewhere

12. 278 - was additional detail provided in none of the 28 studies? This seems a surprise

13. 289 - was risk stratification also provided e.g. EuroSCORE or STS score?

14. Fig 2 - this figure is complex. Would a bubble plot help to show the same data in a more condensed form, with the size of the bubble indicating the size of the study, x being time and y being survival?

15. Fig 3 - this summary figure was much more helpful and easily to interpret

16. 303-313 - complication rates are very difficult to assess when presented in isolation; some of these are common in any age group, some may be likely in certain procedure groups. A more descriptive narrative of the findings would help the reader.

17. The median time for long term mortality follow up needs to be described as this is very subjective in this age group

18. 383 and 317 report different median stays

19. It was not clear what the outcome of the thematic analysis was. Ideally report this in a separate section.

20. Table 3 - is there any way of summarising how many of the studies included reported this minimum dataset?

21. The statistical method of weighting the different studies is not outlined. Please explain how studies contributed to the averages shown.

Overall, I found this study interesting but with several concerns about the precise methodology, as above. I am not an expert in scoping reviews, so have referred to the PRISMA guidance to assess this, but have the impression that this has been largely adhered to. Where there is discrepancy, I have sought to identify where improvements could be made. The relative paucity of experience with scoping reviews in the cardiac surgery literature is not a fault of the authors, but rather one of this reviewer. Nonetheless, the net effect is that the authors must tolerate a more didactic review.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Yousef Tanas

Reviewer #2: Yes:  Pr Thierry CAUS

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Sep 8;20(9):e0331755. doi: 10.1371/journal.pone.0331755.r002

Author response to Decision Letter 1


31 Mar 2025

Professor Marcelo Arruda Nakazone, M.D., Ph.D.

Academic Editor

PLoS ONE

Ref: Resubmission of PONE-D-24-26035

Title: Outcomes and complications in nonagenarians undergoing cardiac surgery: a scoping review

Dear Dr. Nakazone:

My coauthors and I would like to thank you and the expert reviewers for taking the time to provide a very constructive and thoughtful review of our manuscript.

As requested, we have included the following items with our resubmission:

1. A point-by-point response letter (to follow) that addresses each issue raised by the Academic Editor and the Reviewers. I have uploaded this letter as a separate file labelled “Response to Reviewers.”

2. A marked-up copy of the manuscript that highlights changes made to the original version. This has been uploaded as a separate file labelled “Revised Manuscript with Tracked Changes.”

3. An unmarked version of our revised paper without tracked changes. This has also been uploaded as a separate file labelled “Manuscript.”

Journal Requirements

Question 1: Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Authors’ response to Q1: Thank you for this important comment. The text has been edited and formatted and is now consistent with the style guidelines provided above.

Question 2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed: https://bmjopen.bmj.com/content/13/7/e072293.full. In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

Authors’ response to Q2: The manuscript noted at this website (https://bmjopen.bmj.com/content/13/7/e072293.full), entitled “Outcomes and complications of nonagenarians undergoing cardiac surgery: a scoping review protocol” (Ludski et al.) is our earlier publication of the protocol used to guide the study described here. We have now cited this in the text) and also included this as reference #15. As noted in the text, we published the protocol to ensure more effective dissemination, public accessibility, and transparency. Of necessity, we repeated some of the text from this publication (as noted above, minor) to provide clarity throughout.

We are pleased to inform you that we have carefully rephrased any duplicated text in our manuscript titled “https://bmjopen.bmj.com/content/13/7/e072293.full; “Outcomes and complications of nonagenarians undergoing cardiac surgery: a scoping review protocol” (Ludski et al.) to ensure originality and clarity. Additionally, The University of Melbourne has conducted a thorough review using iThenticate to verify that the content does not overlap with our prior publications. The similarity index for the manuscript is below 10%, with all flagged matches appropriately attributed to cited sources. We are happy to provide this information if requested. We are confident these revisions align with the journal’s ethical standards and formatting guidelines.

Should the editorial team or reviewers recommend further adjustments, we are fully committed to addressing them promptly.

Question 3. We note that there is identifying data in the Supporting Information file <Supplementary Table 2 .docx. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory.

Authors’ response to Q3: Thank you for notifying us of this oversight.

Reviewer ONE

We thank Reviewer One for their expert insights and time spent reviewing our manuscript. We have provided a detailed comment to each of the reviewer’s questions, as outlined below.

1. Reviewer 1, comment 1: This systematic review on outcomes and complications in nonagenarians undergoing cardiac surgery addresses a relevant and timely topic. It provides important insights into mortality rates, complications, and hospital stays in this age group. However, there are several areas where the manuscript could be improved.

Strengths: The topic is highly pertinent given the aging population and increasing number of elderly surgical candidates. The literature search is thorough, covering multiple countries and procedures. PRISMA guidelines were followed.

Authors’ response to R1 comment 1: Thank you for these positive comments.

Minor Concerns

2. Reviewer 1, comment 2: The introduction could be streamlined to focus more on the specific gaps in the literature that this review addresses.

Authors’ response to R1 comment 2: Done. The Introduction has been streamlined and now focuses primarily on the goals of the scoping review. Thank you for this constructive comment.

3. Reviewer 1, comment 3: The rationale for excluding non-English articles and certain cardiac procedures could be more clearly explained, as this may limit the generalizability of findings.

Authors’ response to R1 comment 3: We have expanded our rationale for excluding articles not written in English (note that we did include articles with English-language abstracts and had the full papers translated if they fulfilled the study criteria). Interestingly, a 2021 study published by Dobrescu and colleagues in the Journal of Clinical Epidemiology reported that restricting selections to English-language publications appeared to have little impact on the effect estimates and conclusions of systematic reviews. This information has been included together with a new reference [16].

Also, we thought that rather than explaining the cardiac procedures (which would add quite a bit of extra text to the manuscript), the reader might refer to the original studies (references [17-44]) for further details. However, we have expanded the list of cardiac procedures as outlined in the revised manuscript.

4. Reviewer 1, comment 4: The statistical methods are not adequately described. More detail on data synthesis and analysis, particularly handling of heterogeneity (if any) among studies, is needed. The statistical methods used for data synthesis may be described in more detail. While the manuscript mentions the use of descriptive statistics, there is a lack of detail on how these were calculated and whether any meta-analytic techniques were applied. The authors could consider providing a more robust analysis or explaining why certain methods (e.g. meta-analysis) were not feasible.

Authors’ response to R1 comment 4: Thank you for this constructive comment.

The primary aim of our scoping review was to map the available evidence rather than generate a pooled effect estimate. Differences in outcomes or patient characteristics across studies were discussed narratively.

There were several reasons why meta-analytic techniques could not be used in our scoping review. All our included studies typically ranged from very small case series to large observational studies. There were no randomised controlled trials included. Of the 28 studies we included, 20 (71.4%) had less than 50 patients included. There were 12 studies (42.9%) with less than 25 patients. This methodological diversity makes it inappropriate to combine effect sizes statistically. More importantly, many of the outcome measure were variable. Studies reported outcomes such as complications using different definitions. Timeframes, measurement tools also varied preventing direct statistical comparison. The included papers comprised various types of cardiac surgeries, from coronary bypass to complex major aortic interventions, making a single pooled estimate meaningless.

Our data synthesis and analysis were conducted systematically to ensure rigor and reliability. All continuous data were tested for normality using the Kolmogorov–Smirnov test and/or visual inspection of the Q‐Q plot. For data that followed a normal distribution, we reported means and standard deviations, while for non-normally distributed data, we utilized medians and interquartile ranges [IQRs], and ranges (minimum-to-maximum values) to summarize the findings. Differences in categorical variables were assessed using either the Chi-square test or Fisher’s exact test, depending on the sample size and distribution of the data.

In studies where heterogeneity was evident, a narrative synthesis approach was planned to enhance understanding of patient-reported outcomes. This approach involved identifying research gaps through a comparative analysis of study designs and participant characteristics. Additionally, where feasible, thematic analysis was undertaken to explore references to quality-of-life outcomes among nonagenarians. The thematic analysis process included familiarization with the data, generation of codes to capture key concepts related to outcomes, complications, and management strategies. This methodological flexibility allows for the nuanced exploration of the complexity present in the literature while maintaining adherence to a coherent analytical framework. This framework facilitates the identification of knowledge gaps and the recognition of emerging trends within the field.

This has been updated in the resubmission manuscript.

5. Reviewer 1, comment 5: The discussion should more critically evaluate the findings, particularly the high complication rates, and offer a more balanced view on surgical risks and benefits. For example, the implications of the high complication rates could be explored in greater depth, particularly concerning how these might influence surgical decision-making in nonagenarians. The manuscript suggests that age should not be a disqualifying factor for surgery, which is an important point. However, this statement would benefit from a discussion of the balance between risks and benefits, considering patient preferences and quality of life post-surgery.

Authors’ response to R1 comment 5: Thank you for this constructive comment.

We agree that the elevated complication rates observed in nonagenarians undergoing cardiac surgery have significant implications for surgical decision-making in this cohort. Although advanced age alone should not preclude surgical intervention, the heightened risk of complications and mortality warrants careful consideration. Extant literature reports postoperative complication rates reaching 60% in nonagenarians undergoing major surgery, with a one-year mortality rate of approximately 20% following cardiac procedures.

We also agree that these substantial risks necessitate comprehensive discussions with patients and their families to facilitate informed decision-making. Surgeons must carefully balance the potential benefits of surgery against the associated risks, while considering patient preferences and anticipated postoperative quality of life. In assessing surgical candidacy, factors such as frailty, comorbidities, and functional status should be evaluated in conjunction with age. Moreover, the urgency of the procedure is a critical consideration, as elective surgeries generally yield more favorable outcomes compared to urgent or emergent cases. Ultimately, the decision to proceed with cardiac surgery in nonagenarians should be individualized, taking into account not only survival prospects but also the potential for improved functional status and quality of life.

Interestingly, among our major findings, we noted that we could find almost no published information that directly addresses this extremely important question. Although we collected some information on complication rates, which, intriguingly, appear to be somewhat lower than those cited for noncardiac surgery in this population, none of the studies reported patient-centred outcome measures. For example, we could find little to no information on patient days alive and out of the hospital, patient-reported outcome measures, or patient-reported experience measures.

We have taken your suggestion and added additional information and emphasis on this point to the statements regarding age and potential complication rates.

This has been updated in the discussion section under the section titled “Complications”.

6. Reviewer 1, comment 6: The manuscript identifies a lack of patient-reported outcomes but could suggest how future research might address this gap.

Authors’ response to R1 comment 6: Done. In the section addressing Future Directions, we have included a more extensive discussion of tools used to measure these outcomes that might be validated in this very elderly cohort (new references [71,72]).

7. Reviewer 1, comment 7: There are a few typographical errors and grammatical issues throughout the manuscript. A thorough proofreading would be beneficial. For example, the sentence "From the initial 1015 articles searched, we included twenty-eight studies from eight countries were included" is redundant and should be revised for clarity.

Authors’ response to R1 comment 7: The original manuscript has undergone thorough proofreading. All typographical errors and grammatical issues have been addressed, and additional changes have been made to improve clarity and readability throughout.

8. Reviewer 1, comment 8: Ethical Considerations: A discussion of the ethical implications of surgery in nonagenarians, particularly around informed consent, would be valuable.

Authors’ response to R1 comment 8: Done. We have highlighted this specific concern in the Discussion section (with new references [45,46]).

Reviewer TWO

We thank Reviewer Two for their expert insights and time spent reviewing our manuscript. We have provided a detailed comment to each of the reviewer’s questions, as outlined below.

1. Reviewer 2, Comment 1: The authors have to make a choice between a systematic and a scoping review that they seem to assimilate (even in title) but which are two different type of studies with different aim and methodology. See Munn, Z., Peters, M.D.J., Stern, C. et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol 18, 143 (2018). https://doi.org/10.1186/s12874-018-0611-x.

Authors’ response to R2 comment 1: Thank you for this important question. We appreciate the opportunity to clarify our rationale for conducting a scoping review rather than a systematic review.

The primary reason for choosing a scoping review methodology is the current state of the literature in this area. Given the relatively sparse and heterogeneous body of research regarding the outcomes of cardiac surgery in nonagenarians, the use of the scoping review format permitted us to generate a comprehensive map of all available evidence, identify key themes, and highlight gaps in the literature. Unlike a systematic review, which focuses on synthesizing high-quality studies to answer a specific research question, a scoping review provides a broader overview of the extent, range, and nature of the existing research.

Additionally, a scoping review is particularly suited for an emerging or complex area such as this, where variations in study design, outcome measures, and patient cohorts make direct comparison difficult. By capturing a wide spectrum of evidence, including retrospective cohort studies, case series, and observational studies, we can better understand the breadth of available data and assess whether a more targeted systematic review would be feasible in the future. Furthermore, our approach aligns with best practices for evidence synthesis in areas with limited randomized controlled trials or standardized reporting. This methodology enables us to categorize different study types, methodologies, and reported outcomes without the stringent inclusion criteria that a systematic review would necessitate.

In summary, our decision to conduct a scoping review stems from the need to systematically explore and describe the literature landscape in this field. We believe this approach has provided valuable insights into the current knowledge base that

Attachment

Submitted filename: RESPONSE TO REVIEWERS_31March2025.pdf

pone.0331755.s008.pdf (524.8KB, pdf)

Decision Letter 1

Alejandro Torrado Pacheco

23 Jun 2025

Dear Dr. Weinberg,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

The manuscript has been evaluated by two reviewers, and their comments are available below.

The reviewers have raised a number of concerns. They feel the manuscript should be clearer in regards to the methodology used for data aggregation and charting and any limitations thereof, especially as it relates to estimates of mortality rate. The specific section on this (lines 349-369) could benefit from a discussion of these limitations. This is particularly important given the large variability in the number of patients in the studies included in your review. Additionally, the reviewers raised issues with the thematic analysis of patient-reported outcome measures and quality-of-life measures. I understand these were not carried out due to lack of data, but I think the text could be clarified regarding this point (especially e.g. lines 211-217) with an acknowledgement that this was a planned analysis that could not in the end be done.

Could you please carefully revise the manuscript to address all comments raised?

==============================

Please submit your revised manuscript by Aug 04 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Alejandro Torrado Pacheco, Ph.D.

Associated Editor

PLOS One

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #4: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #4: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #4: Yes

**********

Reviewer #1: I appreciate the authors' thorough engagement with all feedback. The manuscript now appears well-prepared.

Reviewer #4: some methodological issues, highlighted in attached document, overall very interesting topic and merits publication with minor adjustments.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Yousef Tanas

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: scoping review open heart surgery on nonagenarians.docx

pone.0331755.s007.docx (19.6KB, docx)
PLoS One. 2025 Sep 8;20(9):e0331755. doi: 10.1371/journal.pone.0331755.r004

Author response to Decision Letter 2


9 Jul 2025

Professor Alejandro Torrado Pacheco, Ph.D.

Associated Editor

PLOS One

9th July 2025

Ref: Second Resubmission of PONE-D-24-26035

Title: Outcomes and complications in nonagenarians undergoing cardiac surgery: a scoping review

Dear Dr. Torrado Pacheco

Once again, my coauthors and I would like to thank you and the expert reviewers for taking the time to provide a very constructive and thoughtful review of our manuscript.

As requested, we have included the following items with our resubmission:

1. A point-by-point response letter (to follow) that addresses each issue raised by the Academic Editor and the Reviewers. I have uploaded this letter as a separate file labelled “Response to Reviewers.”

2. A marked-up copy of the manuscript that highlights in RED changes made to the original version. This has been uploaded as a separate file labelled “Revised Manuscript with Tracked Changes.”

3. An unmarked version of our revised paper without tracked changes. This has also been uploaded as a separate file labelled “Manuscript.”

Comments from the Expert REVIEWERS

Reviewer 1: I appreciate the authors' thorough engagement with all feedback. The manuscript now appears well-prepared.

Authors’ response: We sincerely appreciate the reviewer's recognition of this important research gap. We thank the Reviewer for their take taking to review the resubmission and for the constructive comment above.

Reviewer 4: Some methodological issues, highlighted in attached document, overall very interesting topic and merits publication with minor adjustments.

Authors’ response: Thank you for taking the time to review our manuscript and for providing additional comment. We appreciate the opportunity to further revise our manuscript and enhance the scientific merits of the paper. Please find below a detailed response to each of your comments

Reviewer Q1. Relevant topic, definite gap in the literature with regard to surgery on nonagenarians

Authors’ response to Q1: We sincerely appreciate the reviewer's recognition of this important research gap. The paucity of evidence regarding surgical outcomes in nonagenarians represents a critical knowledge deficit in contemporary cardiac surgery practice. With the global nonagenarian population projected to exceed 30 million by 2030, and increasing prevalence of cardiovascular disease in this demographic, establishing evidence-based outcomes data is essential for informed clinical decision-making.

Our scoping review methodology was specifically chosen to systematically map the available evidence landscape, identify knowledge gaps, and provide a foundation for future research priorities in this rapidly expanding patient population.

Reviewer Q2. Most points have been covered by the preceding 3 reviewers, I only have a couple of additions myself

Authors’ response to Q2: We acknowledge the reviewer's collaborative approach and appreciate the opportunity to address additional methodological considerations that complement the feedback from previous reviewers. This iterative peer review process strengthens the scientific rigor and clinical relevance of our work.

Reviewer Q3. Not sure why a pilot review was necessary, it seems like it was actually the initial step of the review and not a separate or discovery mission

Authors’ response to Q3: Thank you for this important comment that we have discussed with our statistician who is also a co-author on this paper. In hindsight, we agree that the pilot review may not have been necessary. We were however unsure how many papers would need to be screened, and we felt that the pilot review was a standard methodological step to calibrate inter-rater consistency and ensure that inclusion/exclusion criteria were applied consistently before full screening.

We were also cognizant that the pilot review was implemented as a methodological quality assurance measure consistent with established scoping review guidelines. According to the JBI Manual for Evidence Synthesis and PRISMA-ScR recommendations, pilot testing serves multiple critical functions: (1) calibrating reviewer agreement and ensuring consistent application of inclusion/exclusion criteria, (2) validating data extraction instruments, and (3) identifying potential methodological challenges before full-scale implementation.

As described in the Methods, “Study selection and screening procedure”, this step helped refine our screening tool, improve reviewer agreement, and ensured methodological transparency consistent with PRISMA-ScR and Levac et al.’s framework. Our pilot demonstrated substantial inter-rater reliability (Cohen's kappa = 0.643, 95.6% concordance), which provided methodological confidence for the complete review. Whilst this approach is not always routine in scoping reviews it enabled a robust and systematic synthesis of the evidence and ensured reproducibility and reliability of findings.

Reviewer Q4. I do agree with one of the reviews that there is some overlap between scoping and systematic reviews in this study, the study should, strictly speaking, report on the available literature, without seeking to synthesise it as that is the objective of a systematic review, as stated by the authors in line 147. for example, it is difficult to understand how they came up with the mortality rate of 10.5% when there is so much heterogeneity between the studies, with some studies having as small a sample of 9 and others as large a sample as over 2000, adding means from such differently powered studies may give an inaccurate result without weighting, which cannot be done for heterogenous studies.

Authors’ response to Q4: We acknowledge the reviewer's important observation regarding methodological boundaries between scoping and systematic reviews. However, our approach aligns with established scoping review methodology as outlined in the PRISMA-ScR guidelines. Scoping reviews legitimately provide descriptive numerical summaries of available evidence without formal meta-analytical synthesis. The reported median mortality rate of 10.5% (IQR 7.2–14.6%) represents a descriptive statistic of the available evidence landscape, not a weighted pooled meta-analytical estimate. This has been added in to the Results sections (Lines 230-232)

We calculated medians and interquartile ranges precisely because of the heterogeneity you identify-this approach is less sensitive to extreme values and varying sample sizes than weighted means would be. The primary objective was to map the breadth of available evidence and identify patterns, which differs fundamentally from systematic review synthesis that would require formal quality assessment and meta-analytical techniques with appropriate weighting strategies.

Given this important comment, we have amended the Results and Discussion sections to more explicitly clarify that our findings are descriptive and derived from unweighted medians rather than means or pooled statistics, to avoid overinterpretation.

Reviewer Q5. It is interesting to see the huge discrepancy in reported mortality rate in nonagenarians undergoing open heart surgery (10.5%) compared to nonagenarians undergoing non cardiac surgery (38%), It is difficult to believe that there is a reversal in the mortality rate in non-cardiac surgery compared to open cardiac surgery observed in the general population compared to that in such a high risk population. After all, a recent study in Italy identified the mortality in non-surgical nonagenarians to be 20.3% (Pancani, S., Lombardi, G., Sofi, F. et al. 12-month survival in nonagenarians inside the Mugello study: on the way to live a century. BMC Geriatr 22, 194 (2022). https://doi.org/10.1186/s12877-022-02908-9). While the authors ascribe it to careful patient selection in cardiac surgery, could other factors have contributed, such as the statistical analysis problems mentioned above? Or if indeed this is a true result, could it be that this represents the findings in first-world countries, as most of the data was obtained from high-income countries?

Authors’ response to Q5: The reviewer raises an astute observation about the apparent mortality paradox. We have included an additional paragraph in the discussion section that provided deeper insights. In the discussion section (Lines 357-369) we now state:

“Several factors beyond the statistical methods are likely to have contributed to this counterintuitive finding. First, the stringent patient selection for cardiac surgery in nonagenarians creates a highly selected cohort: patients must demonstrate adequate physiological reserves, cognitive function, and life expectancy to justify the procedural risk. In contrast, non-cardiac surgery populations might include emergent presentations with less rigorous preoperative optimization. Second, the availability of transcatheter alternatives might selectively direct higher-risk nonagenarians away from open surgery. Frail patients might be triaged toward transcatheter aortic valve replacement or medical management, thus further contributing to the lower observed mortality. Third, the reported increase in mortality of nonagenarians undergoing non-cardiac surgery represents a general nonagenarian population rather than a highly selected cardiac-surgery cohort. Fourth, the data reflect predominantly high-income countries with advanced perioperative care systems, specialized cardiac surgery centers, and comprehensive postoperative support.

In the limitations section (Lines 513-515), we have also added a cautionary note about generalizing these results to lower-resource settings where risk profiles and outcomes may differ significantly. We now state “Finally, our findings cannot be generalized to lower-resource settings or lower- and middle-income countries, where risk profiles and outcomes may differ significantly.”

Reviewer Q6. No mention as to whether the procedures documented were performed as elective or emergency procedures as the mortality rate may differ significantly between elective and emergency cardiac surgery

Authors’ response to Q6: Thank you for raising this excellent point. We have reviewed each included paper once again to see if this was documented or captured in the original publication. Unfortunately, most included studies did not stratify outcomes based on surgical urgency.

We acknowledge this limitation (See lines 489-491), where we now state: “Unfortunately, most included studies did not stratify outcomes by surgical urgency, thus constraining our ability to evaluate the differential effects of elective vs. emergent procedures.” This omission constrains our ability to evaluate the differential impact of elective vs. emergent procedures. We have added this limitation to the Discussion as above, and updated Table 3 to recommend that future studies report surgical urgency as a key preoperative variable for risk stratification.

Reviewer Q7. Scoping review objectives differ between the introduction and the objectives, could do with some clarity, the third objective (Proms) was not met as there was insufficient data

Authors’ response to Q7: Thank you for highlighting this discrepancy. We acknowledge the need for clarity between our introduction and formal objectives.

The apparent discrepancy reflects the evolution from our initial comprehensive research questions to the practical limitations encountered during evidence mapping. While we initially aimed to evaluate PROMs and PREMs comprehensively, the complete absence of such data in the literature necessitated reframing this as a critical gap identification rather than a quantitative analysis.

Both PREMS and PROMS represents legitimate scoping review outcomes-identifying what evidence exists and, equally importantly, what evidence is absent. We have clarified our objectives to reflect that PROMs/PREMs assessment was exploratory, with the understanding that absence of such data would itself constitute a significant finding. While PROMs and PREMs were included as objectives to identify literature gaps, we now explicitly state that no data were available, thus rendering that objective unmet. This reinforces the central finding of our review: a significant absence of patient-centered outcomes in this demographic.

We have revised the Introduction and Methods to ensure alignment with the final objectives stated.

• In the methods section (Lines 89-93) we state: “Finally, as an exploratory outcome, the review identified whether patient-reported outcomes (PROMs) and experience measures (PREMs) have been included in studies examining outcomes in nonagenarians undergoing cardiac surgery, given that an absence of such data would itself constitute a notable finding.”

• In the data synthesis and analysis section (Lines 211-213) we state: “Our approach can therefore be accurately described as a narrative synthesis of quantitative findings, organized thematically around clinical domains (mortality, morbidity, and length of stay).”

• In the section Patient-reported experience and outcomes measures section (Lines 320-321) we state: “None of the included studies reported PROMs or PREMs; therefore, this study objective was unmet.”

Reviewer Q8. According to the comments made in response to previous reviewer comments, no data could be found regarding patient satisfaction measures, yet it is mentioned in the objectives and methods under data extraction, and discussion see lines 92, 194, 195,204, 211,212 and 331 etc. Should this section then not be removed from the objectives and methods, and a comment made only in the discussion, identifying it as a gap in the literature?

Authors’ response to Q8: The reviewer correctly identifies an apparent inconsistency in our methodology. This has been corrected, and this section has been removed from the objectives and methods.

• The methods section (Lines 89-93) states: “Finally, as an exploratory outcome, the review identified whether patient-reported outcomes (PROMs) and experience measures (PREMs) have been included in studies examining outcomes in nonagenarians undergoing cardiac surgery, given that an absence of such data would itself constitute a notable finding.”

The methodology sections appropriately described our comprehensive search strategy, while the results and discussion sections report the significant finding that no such data exists. This absence of patient-centered outcome measures represents a critical knowledge gap that our review identified.

Reviewer Q9. Again in the data analysis section we find some overlap in terms of methodology, thematic analysis is a qualitative analytic tool and depends on the conceptual framework and selection of appropriate paradigm, the context of which is of the utmost importance, this makes it technically difficult to code and draw themes from an analysis of retrospective quantitative data obtained from thousands of patients who had different research tools used in many varying countries with differing languages, especially as no patient satisfaction measures were identified in the data, the appropriate analysis of such data in the case of a scoping review is simply narrative

Authors’ response to Q9: The reviewer raises important considerations about thematic analysis methodology. We acknowledge that our use of the term "thematic analysis" may be imprecise in this context. Given the absence of qualitative data or patient-reported outcomes in the included studies, formal thematic analysis was indeed impossible. Our approach is more accurately described as narrative synthesis of quantitative findings, organized thematically around clinical domains (mortality, morbidity, length of stay).

We have revised our methodology description to more accurately reflect this narrative approach rather than formal thematic analysis, which requires qualitative data and interpretive frameworks as the reviewer correctly notes. Given the paucity of such data, we have removed thematic analysis from our stated analytical methods and revised the Data Analysis section to reflect a narrative synthesis alone. These changes help ensure methodological consistency and prevent overreach.

Thank you for this important suggestion.

Reviewer Q10. According to the authors, the majority

Attachment

Submitted filename: Response letter_PLOS_One_9July2025.pdf

pone.0331755.s009.pdf (512.7KB, pdf)

Decision Letter 2

Redoy Ranjan

21 Aug 2025

Outcomes and complications among nonagenarians undergoing cardiac surgery: a scoping review

PONE-D-24-26035R2

Dear Dr. Weinberg,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Dr Redoy Ranjan, MBBS, MRCSEd, Ch.M., MS (CV&TS), FACS

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #4: Yes

**********

Reviewer #4: (No Response)

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #4: Yes:  Mulai Slave

**********

Acceptance letter

Redoy Ranjan

PONE-D-24-26035R2

PLOS ONE

Dear Dr. Weinberg,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Redoy Ranjan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist.

    (DOCX)

    pone.0331755.s001.docx (47.5KB, docx)
    S2 Table. Full search strategies for all electronic databases.

    (DOCX)

    pone.0331755.s002.docx (18.5KB, docx)
    S3 Table. Cardiopulmonary bypass and aortic cross-clamp: times reported by the publications included in the review.

    (DOCX)

    pone.0331755.s003.docx (18.5KB, docx)
    S4 Table. Overall complication rates listed by type.

    (DOCX)

    pone.0331755.s004.docx (17.7KB, docx)
    S5 Table. Length of hospital and intensive care stay.

    (DOCX)

    pone.0331755.s005.docx (17.2KB, docx)
    Attachment

    Submitted filename: RESPONSE TO REVIEWERS_31March2025.pdf

    pone.0331755.s008.pdf (524.8KB, pdf)
    Attachment

    Submitted filename: scoping review open heart surgery on nonagenarians.docx

    pone.0331755.s007.docx (19.6KB, docx)
    Attachment

    Submitted filename: Response letter_PLOS_One_9July2025.pdf

    pone.0331755.s009.pdf (512.7KB, pdf)

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES